Centocor Ortho Biotech Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Centocor Ortho Biotech Inc..The latest application filed is for "engineered plant cysteine proteases and their uses".

Company Profile

5.32.6

Centocor Ortho Biotech Inc. - Horsham PA
Centocor Ortho Biotech Inc. - Berwyn PA US
Centocor Ortho Biotech, Inc. - Malvern PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Polynucleotides encoding engineered plant cysteine proteases and their uses Grant 8,759,067 - Chi , et al. June 24, 2	2014-06-24
Display of disulfide linked dimeric proteins in filamentous phage Grant 8,728,985 - Huang , et al. May 20, 2	2014-05-20
Anti-CD147 antibodies, methods and uses Grant 08618264 -	2013-12-31
Anti-CD147 antibodies, methods and uses Grant 8,618,264 - Cunningham , et al. December 31, 2	2013-12-31
Anti-TNF alpha fibronectin type III domain based scaffold compositions, methods and uses Grant 8,617,894 - Jacobs , et al. December 31, 2	2013-12-31
Anti-TNF alpha fibronectin type III domain based scaffold compositions, methods and uses Grant 08617894 -	2013-12-31
Fusion proteins of alpha-MSH derivatives and Fc Grant 8,614,185 - Heavner December 24, 2	2013-12-24
Engineered plant cysteine proteases and their uses App 20130196413 - Chi; Ellen ; et al.	2013-08-01
Bacterial membrane protein secretion Grant 8,450,086 - Huang , et al. May 28, 2	2013-05-28
Engineered potato virus A nuclear inclusion protein Grant 8,426,186 - Chi , et al. April 23, 2	2013-04-23
Anti-TNF alpha fibronectin type III domain based scaffold compositions, methods and uses Grant 8,415,291 - Jacobs , et al. April 9, 2	2013-04-09
Engineered anti-IL-13 antibodies, compositions, methods and uses Grant 8,399,630 - Swanson , et al. March 19, 2	2013-03-19
Baboon homolog of human CD147 Grant 8,338,171 - Swencki-Underwood , et al. December 25, 2	2012-12-25
Cells expressing pluripotency markers and expressing markers characteristic of the definitive endoderm Grant RE43,876 - Rezania December 25, 2	2012-12-25
Engineered anti-IL-13 antibodies, compositions, methods and uses Grant 8,323,646 - Swanson , et al. December 4, 2	2012-12-04
Monkey homolog of human oncostatin M and methods of use thereof Grant 8,309,688 - Cotty , et al. November 13, 2	2012-11-13
Fibronectin type III domain based scaffold compositions, methods and uses Grant 8,293,482 - Jacobs , et al. October 23, 2	2012-10-23
Fibronectin type III domain based scaffold compositions, methods and uses Grant 8,278,419 - Jacobs , et al. October 2, 2	2012-10-02
Serum Markers Predicting Clinical Response to Anti-TNF Alpha Antibodies in Patients with Psoriatic Arthritis App 20120178100 - Wagner; Carrie ; et al.	2012-07-12
Enhancement of hybridoma fusion efficiencies through cell synchronization Grant 8,216,842 - Giles-Komar , et al. July 10, 2	2012-07-10
Anti-alpha V immunoliposome compositions, methods and uses Grant 8,138,315 - Goldstein , et al. March 20, 2	2012-03-20
Nucleic acids encoding cynomolgus IL-13 mutein proteins Grant 8,088,600 - O'Neil , et al. January 3, 2	2012-01-03
Polynucleotides encoding Papio cynocephalus toll-like receptor 3 Grant 8,084,232 - Jordan , et al. December 27, 2	2011-12-27
Differentiation of Human Embryonic Stem Cells App 20110281355 - XU; JEAN	2011-11-17
Selection of high-producing cell lines Grant 8,017,325 - Dorai September 13, 2	2011-09-13
Methods for Purifying Cells Derived from Pluripotent Stem Cells App 20110212067 - Karanu; Francis ; et al.	2011-09-01
Methods for assessing response to therapy in subjects having ulcerative colitis Grant 7,943,310 - Li , et al. May 17, 2	2011-05-17
Cells expressing pluripotency markers and expressing markers characteristic of the definitive endoderm Grant 7,939,322 - Rezania May 10, 2	2011-05-10
Pluripotent Stem Cells App 20110104805 - Fung; Ramie ; et al.	2011-05-05
Human anti-IL-23 antibodies, compositions, methods and uses Grant 7,935,344 - Benson , et al. May 3, 2	2011-05-03
Cynomolgus gp80 receptor and uses thereof Grant 7,931,905 - Naso , et al. April 26, 2	2011-04-26
Anti-IL-12 antibodies and compositions Grant 7,887,807 - Giles-Komar , et al. February 15, 2	2011-02-15
Macaca fascicularis ST2L Grant 7,879,978 - Cotty , et al. February 1, 2	2011-02-01
IL-23p40 specific immunoglobulin derived proteins, compositions, epitopes, methods and uses Grant 7,807,471 - Benson , et al. October 5, 2	2010-10-05
Anti-IL-23 antibodies, compositions, methods and uses Grant 7,807,414 - Benson , et al. October 5, 2	2010-10-05
Methods of treating pulmonary fibrosis Grant 7,754,207 - Glass , et al. July 13, 2	2010-07-13
Cynomolgus Il-13 Mutein Proteins, Antibodies, Compositions, Methods And Uses App 20100129318 - O'Neil; Karyn ; et al.	2010-05-27
Nucleic acids encoding anti-IL-12 antibodies, and methods of production Grant 7,560,247 - Giles-Komar , et al. July 14, 2	2009-07-14
Anti-il-6 antibodies, compositions, methods and uses Grant 7,560,112 - Chen , et al. July 14, 2	2009-07-14
Growth arrest specific gene 6 peptides, antibodies, compositions, methods and uses Grant 7,547,767 - Yang , et al. June 16, 2	2009-06-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.